rs1044543244
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_006567.5(FARS2):c.638A>G(p.Glu213Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000168 in 1,605,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FARS2 | ENST00000274680.9 | c.638A>G | p.Glu213Gly | missense_variant | Exon 3 of 7 | 1 | NM_006567.5 | ENSP00000274680.4 | ||
| FARS2 | ENST00000324331.10 | c.638A>G | p.Glu213Gly | missense_variant | Exon 3 of 7 | 1 | ENSP00000316335.5 | |||
| FARS2 | ENST00000445533.1 | c.26A>G | p.Glu9Gly | missense_variant | Exon 1 of 3 | 3 | ENSP00000392525.1 | |||
| FARS2 | ENST00000648580.1 | n.638A>G | non_coding_transcript_exon_variant | Exon 3 of 9 | ENSP00000497889.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000404 AC: 1AN: 247326 AF XY: 0.00000748 show subpopulations
GnomAD4 exome AF: 0.0000179 AC: 26AN: 1452960Hom.: 0 Cov.: 30 AF XY: 0.0000194 AC XY: 14AN XY: 722260 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74376 show subpopulations
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 14 Uncertain:2
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 213 of the FARS2 protein (p.Glu213Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 587656). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FARS2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at